Profile
ALVOW TAK ZTS HLN TEVA VTRS
Company Name Alvotech Takeda Pharmaceutical Company Limited Zoetis Inc. Haleon plc Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $90.64M $58.57B $55.37B $50.61B $39.37B $18.41B
Employees 1.01K 49.28K 13.80K 24.56K 37.00K 32.00K
CEO Vilhelm Robert Wessman Christophe Weber Kristin C. Peck Brian James McNamara Richard D. Francis Scott Andrew Smith
Ratings
ALVOW TAK ZTS HLN TEVA VTRS
Quant Rating Score 2 3 3 4 3 2
Quant Rating Sell Neutral Neutral Buy Neutral Sell
Trading
ALVOW TAK ZTS HLN TEVA VTRS
Last Close $0.7821 $14.14 $118.8 $9.68 $24.59 $10.66
High 52 $3.84 $15.52 $178.71 $11.41 $25.83 $13.37
Low 52 $0.62 $12.89 $118.8 $8.73 $12.82 $7.26
Price vs. 52 Week High -79.63 % -8.89 % -33.52 % -15.16 % -4.8 % -20.27 %
Price vs. 52 Week Low 26.15 % 9.7 % 0 % 10.88 % 91.81 % 46.83 %
Total Return
ALVOW TAK ZTS HLN TEVA VTRS
1 Month Return -54.26 % 0.71 % -17.53 % 2.11 % 27.34 % 4.82 %
3 Month Return -37.43 % -6.73 % -21.96 % -0.05 % 36.16 % 0.28 %
6 Month Return -60.1 % 0.21 % -27.13 % -10.37 % 45.16 % 20.59 %
9 Month Return -68.08 % 1.73 % -24.08 % -3.1 % 48.4 % -1.84 %
YTD Return -74.85 % 6.8 % -27.09 % 1.47 % 11.57 % -14.38 %
1 Year Return -76.72 % 3.82 % -32.33 % 2.11 % 46.28 % -18.31 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ALVOW TAK ZTS HLN TEVA VTRS
Dividend Yield Percentage (TTM) - 3.4 % 1.62 % 1.35 % - 3 %
Dividend Paid and Capex Coverage Ration (TTM) -0.3 % 2.23 % 1.89 % 2.01 % 4 % 2.09 %
Dividend Per Share (TTM) - 198 % 2.03 % 0.06 % - 0.48 %
Payout Ratio (TTM) - 277.04 % 32.55 % 27.27 % - -15.34 %
Growth
ALVOW TAK ZTS HLN TEVA VTRS
Asset Growth 28.56 % -0.34 % 0.76 % 3.61 % -12.97 %
Gross Profit Growth 538.44 % 9.63 % -0.19 % 10.86 % -12.66 %
Revenue Growth 435.56 % 8.33 % -0.61 % 4.32 % -4.46 %
Revenue 3 Year 55.32 % 24.31 % 19.01 % 11.71 % -16.52 %
Revenue 5 Year 1295.18 % 55.65 % 33.95 % -1.27 % -39.86 %
Revenue 10 Year 1295.18 % 113.39 % 33.95 % -34.65 % -36.45 %
EBIT Growth 87.72 % 5.67 % 13.52 % -9.52 % -109.43 %
Net Income Growth 57.98 % 6.06 % 37.46 % 185.97 % -1259.41 %
Net Income 3 Yeari Growth Per Share 73.36 % 27.46 % 4.91 % 155.65 % 49.38 %
Net Income 5 Yeari Growth Per Share -0.47 % 74.46 % 122.63 % 133.65 % -1871.56 %
Net Income 10 Yeari Growth Per Share -0.47 % 370.4 % 122.63 % -33.98 % -122.71 %
Operating Income Growth 119.63 % 10.52 % 10.52 % 1131.35 % -98.68 %
Operating Cash Flow Growth (CFG) 24.13 % 25.5 % 9.57 % -35.33 % -17.74 %
Operating 3 Year CFG 87.89 % 39.36 % 71.6 % 0.19 % -22.68 %
Operating 5 Year CFG -143.24 % 73.18 % 196.04 % 29.24 % -40.08 %
Operating 10 Year CFG -143.24 % 420.39 % 196.04 % -77.86 % -24.47 %
EPS Growth 64.2 % 7.68 % 33.33 % 184.83 % -1262.28 %
EPS Diluted Growth 64.2 % 7.89 % 33.33 % 182.76 % -1269.98 %
Book Value Per Share 62.45 % -2.96 % -1.63 % 36.19 % -8.42 %
Share Holder 3 Year Equity Growth Per Share 64.5 % 9.65 % -37.97 % -2.08 % -7.88 %
Share Holder 5 Year Equity Growth Per Share - 85.42 % -40.16 % -24.81 % -26.41 %
Share Holder 10 Year Equity Growth Per Share - 301.38 % -40.16 % -80.23 % 90.51 %
Dividend Per Share Growth - 15.33 % 49.01 % - 0.45 %
Dividend 3 Year Growth Per Share - 73.18 % -49.79 % - 45.93 %
Dividend 5 Year Growth Per Share - 163.51 % -49.97 % - -
Dividend 10 Year Growth Per Share - 493.89 % -49.97 % -100 % -
Debt Growth 10.67 % -0.16 % 6.83 % -3.86 % -22.13 %
Free Cash Flow Growth 18.07 % 41.76 % 16.27 % -43.99 % -14.98 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2025 31 Dec 2024
Profitability
ALVOW TAK ZTS HLN TEVA VTRS
Gross Profit Margin TTM 55.42 % 59.49 % 70.63 % 61.81 % 51.76 % 36.07 %
Return on Assets TTM 4.93 % 0.73 % 17.49 % 4.78 % 3.48 % -9.73 %
Return on Equity TTM -26.11 % 1.58 % 53.56 % 9.4 % 20.09 % -22.69 %
Return on Capital Employed TTM 3.93 % 3.59 % 26.48 % 8.34 % 11.54 % -8.43 %
Net Income Per EBT TTM 133.05 % 54.99 % 79.59 % 76.52 % 114.62 % 95.92 %
EBT Per Ebit TTM 120.22 % 44.75 % 94.2 % 88.09 % 39.3 % 149.32 %
EBIT Per Revenue TTM 7.61 % 10.28 % 37.63 % 20.49 % 18.15 % -18.25 %
Cash Flow To Debt Ratio TTM -2.07 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Receivables Turnover TTM 4.71 5.89 6.1 5.14 4.68 3.94
Payables Turnover TTM 2.78 3.87 6.73 1.18 3.31 6.81
Inventory Turnover TTM 1.23 1.29 1.12 3.72 2.63 2.2
Fixed Asset Turnover TTM 115.58 % 214.23 % 241.44 % 589.57 % 392.13 % 488.38 %
Asset Turnover TTM 40.53 % 28.97 % 61.99 % 34.62 % 42.58 % 37.25 %
Operating Cash Flow Per Share TTM -0.09 710.55 6.58 0.11 1.76 1.7
Free Cash Flow Per Share TTM -0.38 589.53 5.06 0.1 1.32 1.37
Cash Per Share TTM 14.27 % 48236.45 % 470.54 % 7.46 % 309.55 % 99.36 %
Operating Cash Flow Sales Ratio TTM -4.64 % 25.14 % 31.03 % 9.32 % 11.64 % 14.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 428.35 % 82.97 % 76.82 % 90.65 % 74.99 % 80.65 %
Cash Flow Coverage Ratios TTM -2.07 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Price To Free Cash Flows Ratio TTM -12.74 9.86 24.72 39.77 26.1 11.51
Price To Operating Cash Flows Ratio TTM -52.6 8.18 19.08 36.66 19.61 9.39
Price Cash Flow Ratio TTM -52.6 8.18 19.08 36.66 19.61 9.39
Income Statement (TTM)
ALVOW TAK ZTS HLN TEVA VTRS
Revenue $0.49B $4581.55B $9.47B $11.23B $17.26B $14.74B
Gross Profit $0.3B $3001.33B $6.67B $6.95B $8.94B $5.62B
Gross Profit Ratio 62.16% 65.51% 70.49% 61.85% 51.79% 38.15%
EBITDA $-0.03B $1210.51B $4.07B $2.51B $3.14B $2.82B
Net Income $-0.23B $107.93B $2.67B $1.44B $1.41B $-0.63B
EPS Diluted -0.87 33.62 6.02 0.32 1.2 -0.53
Balance Sheet (MRQ)
ALVOW TAK ZTS HLN TEVA VTRS
Long Term Debt $1.15B $3966.33B $9.44B $8.62B $15.56B $14.22B
Total Liabilities $1.63B $7312.37B $12.14B $18.09B $32.83B $22.87B
Total Equity $-0.41B $6935.98B $3.33B $16.22B $7.91B $18.64B
Total Investments $0.02B $382.4B $0B $0.14B $0B $1.7B
Total Debt $1.19B $4515.27B $9.49B $10.1B $17.38B $14.31B
Total Assets $1.22B $14248.34B $15.47B $34.32B $40.75B $41.5B
Cash Flow Statement (TTM)
ALVOW TAK ZTS HLN TEVA VTRS
Net Income $-0.23B $107.93B $2.67B $1.44B $1.42B $-0.63B
Inventory $-0.05B $-34.97B $-0.2B $0.22B $0.15B $-0.72B
Dividends Paid $0B $-302.5B $-0.89B $-0.57B $0B $-0.57B
Operating Cash Flow $-0.24B $1057.18B $2.9B $2.3B $1.65B $2.3B
Capital Expenditure $-0.06B $-200.8B $-0.62B $-0.25B $-0.5B $-0.33B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 3.78
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 0.9002
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 4.14
AMPH Amphastar Pharmaceuticals, Inc. 28.51
AMRX Amneal Pharmaceuticals, Inc. 14.5
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 77.78
APUS Apimeds Pharmaceuticals US, Inc 1.389
AQST Aquestive Therapeutics, Inc. 3.945
ASRT Assertio Holdings, Inc. 11.73
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 21.64
AYTU Aytu BioPharma, Inc. 2.3
Unlock